Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-19 Purchase |
2022-08-22 3:27 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
200,000 | $11.46 | $2,292,460 | 55,844,391 (Direct) |
View |
| 2022-06-13 Purchase |
2022-06-15 1:14 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
64,088 | $8.0344 | $514,908 | 55,644,391 (Direct) |
View |
| 2022-06-06 Purchase |
2022-06-08 3:32 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
64,545 | $7.4981 | $483,965 | 55,580,303 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-17 3:07 pm |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
200,000 | $6.3389 | $1,267,780 | 9,260,340 (Indirect Direct) |
View |
| 2022-05-13 Purchase |
2022-05-17 3:04 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
300,000 | $7.2551 | $2,176,530 | 55,515,758 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-16 2:14 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
1,408,468 | $6.4054 | $9,021,801 | 55,215,758 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-16 2:13 pm |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
85,000 | $5.79 | $492,150 | 269,459 (Indirect Direct) |
View |
| 2022-03-04 Purchase |
2022-03-04 4:51 pm |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
10,000 | $8.54 | $85,400 | 61,000 (Indirect Direct) |
View |
| 2022-03-01 Purchase |
2022-03-03 12:06 pm |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
20,000 | $9.05 | $181,000 | 51,000 (Indirect Direct) |
View |
| 2022-02-28 Purchase |
2022-03-01 7:49 pm |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
230,789 | $8.66 | $1,998,633 | 9,060,340 (Indirect Direct) |
View |
| 2021-11-11 Purchase |
2021-11-15 06:05 am |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
67,500 | $14.71 | $993,130 | 184,459 (Indirect Direct) |
View |
| 2021-11-11 Purchase |
2021-11-15 06:05 am |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
202,960 | $14.76 | $2,995,913 | 55,807,290 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-01 Option Award |
2022-12-05 12:19 pm |
N/A 2032-12-01 |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
485,661 | $0 | 5,870,481 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 12:13 pm |
N/A 2032-12-01 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
925,069 | $0 | 6,613,691 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-21 9:36 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 61,912,013 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-21 9:36 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 61,912,013 (Direct) |
View |
| 2022-10-31 Gift |
2022-11-09 7:31 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
70,000 | $0 | 55,774,391 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 3:09 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 61,782,013 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 3:09 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 61,782,013 (Direct) |
View |
| 2022-05-18 Exercise |
2022-05-19 1:17 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 61,653,380 (Direct) |
View |
| 2022-05-18 Exercise |
2022-05-19 1:17 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 61,653,380 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-25 1:50 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 59,944,912 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-25 1:50 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 59,944,912 (Direct) |
View |
| 2021-11-30 Ownership |
2022-02-03 7:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
333,333 | $0 | 8,829,551 (Direct) |
View |
Ownership |
2022-02-03 7:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
0 | $0 | 8,829,551 (Indirect) |
View |
| 2021-05-24 Ownership |
2022-02-03 6:58 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
2,000,000 | $0 | 53,807,290 (Direct) |
View |
| 2021-05-24 Ownership |
2022-02-03 6:56 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
2,223,500 | $0 | 54,031,790 (Indirect) |
View |
Ownership |
2022-02-03 6:56 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
0 | $0 | 54,031,790 (Direct) |
View |
| 2021-12-10 Ownership |
2022-02-03 6:54 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
500,000 | $0 | 184,459 (Direct) |
View |
Ownership |
2022-02-03 6:54 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
0 | $0 | 184,459 (Indirect) |
View |
| 2021-12-10 Exercise |
2021-12-10 5:00 pm |
2020-03-23 2029-08-22 |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
500,000 | $0 | 6,069,279 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-10 5:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
500,000 | $0.32 | 6,069,279 (Direct) |
View |
| 2021-12-03 Option Award(A) |
2021-12-10 2:36 pm |
N/A 2031-12-03 |
AbCellera Biologics Inc. | ABCL | Lo Andrew Director |
91,325 | $0 | 91,325 (Direct) |
View |
| 2021-08-27 Option Award |
2021-12-10 1:15 pm |
2022-08-27 2031-08-27 |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
79,814 | $0 | 1,145,096 (Direct) |
View |
| 2021-08-27 Option Award |
2021-12-10 1:13 pm |
2022-08-27 2031-08-27 |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
79,814 | $0 | 2,515,738 (Direct) |
View |
| 2021-12-07 Option Award |
2021-12-09 6:01 pm |
N/A 2031-12-07 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
406,020 | $0 | 12,009,705 (Direct) |
View |
| 2021-12-07 Option Award |
2021-12-09 6:00 pm |
N/A 2031-12-07 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
920,312 | $0 | 62,178,412 (Direct) |
View |
| 2021-12-07 Option Award |
2021-12-09 5:58 pm |
N/A 2031-12-07 |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
406,020 | $0 | 6,069,279 (Direct) |
View |
| 2021-12-07 Option Award |
2021-12-09 5:55 pm |
N/A 2031-12-07 |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
270,680 | $0 | 2,311,980 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-09 5:49 pm |
N/A 2027-03-23 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
250,000 | $0 | 11,603,685 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-09 5:49 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
250,000 | $0.19 | 11,603,685 (Direct) |
View |
| 2021-11-30 Exercise(A) |
2021-12-03 5:47 pm |
N/A 2027-03-23 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
83,333 | $0 | 11,687,018 (Direct) |
View |
| 2021-11-30 Exercise(A) |
2021-12-03 5:47 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
83,333 | $0.19 | 11,687,018 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 2:16 pm |
N/A 2027-03-23 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
83,333 | $0 | 11,687,018 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 2:16 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
83,333 | $14.96 | 11,687,018 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-22 5:03 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
224,500 | $15.03 | 61,258,100 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-22 5:03 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
224,500 | $0 | 61,258,100 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 4:12 pm |
N/A 2029-09-11 |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
270,000 | $0 | 1,661,642 (Indirect) |
View |
| 2021-09-13 Exercise |
2021-09-15 4:12 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
270,000 | $17.73 | 1,661,642 (Indirect) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:18 pm |
N/A 2029-01-01 |
AbCellera Biologics Inc. | ABCL | Falconer Ester Chief Technology Officer |
875,000 | $0 | 1,750,000 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:18 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Falconer Ester Chief Technology Officer |
875,000 | $16.89 | 1,750,000 (Direct) |
View |